MILNACIPRAN HYDROCHLORIDE
MACLEODS PHARMS · MILNACIPRAN HYDROCHLORIDE
Open FDA's page for this record- Application number
- ANDA210944
- Sponsor name
- MACLEODS PHARMS
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260915
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Application docs
- ID
- 86104
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/210944Orig1s000TAltr.pdf
- Date
- 20260602
- Type
- Letter
- Products
- Product number
- 003
- Reference drug
- No
- Brand name
- MILNACIPRAN HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- MILNACIPRAN HYDROCHLORIDE
- Strength
- 50MG
- Product number
- 001
- Reference drug
- No
- Brand name
- MILNACIPRAN HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- MILNACIPRAN HYDROCHLORIDE
- Strength
- 12.5MG
- Product number
- 004
- Reference drug
- No
- Brand name
- MILNACIPRAN HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- MILNACIPRAN HYDROCHLORIDE
- Strength
- 100MG
- Product number
- 002
- Reference drug
- No
- Brand name
- MILNACIPRAN HYDROCHLORIDE
- Reference standard
- No
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- MILNACIPRAN HYDROCHLORIDE
- Strength
- 25MG
